Friday June 23rd 2017

Archive for February, 2012

Health minister tries to block bill backing controversial MS therapy

Health minister tries to block bill backing controversial MS therapy

Health Minister Leona Aglukkaq has sparked anger by aggressively opposing a private member’s bill that would accelerate clinical trials of so-called liberation therapy for people with multiple sclerosis. The private member’s bill, sponsored by Liberal MP Kirsty Duncan, [Read More]

Application closes for MS Liberation treatment study in New York

Application closes for MS Liberation treatment study in New York

For hundreds Multiple Sclerosis patients in Saskatchewan the next few months will be spent waiting. On Friday, February 24 the deadline closed for the provincially funded MS Liberation Treatment trial in Albany, New York. The government received 682 applications to be part [Read More]

MS trial in Saskatchewan attracts nearly 700 patients

MS trial in Saskatchewan attracts nearly 700 patients

Saskatchewan multiple sclerosis patients hoping to take part in a clinical trial of a controversial treatment may soon get a call from the ministry of health. But only around 10 per cent of those who applied will actually get that call. Deb Jordan, a ministry spokeswoman, [Read More]

 Page 1 of 5  1  2  3  4  5 »

Latest Topics

MS Society Hosts Joint Congressional Briefing on the Value of Rehabilitation

MS Society Hosts Joint Congressional Briefing on the Value of Rehabilitation

/About-the-Society/News/Society-Hosts-Joint-Congressional-Briefing-on-the [Read More]

MS Society Disappointed with Senate Healthcare Bill

MS Society Disappointed with Senate Healthcare Bill

/About-the-Society/News/HealthcareBill-6-22 [Read More]

Type I interferons could have role in natural improvement of RA during pregnancy

Type I interferons could have role in natural improvement of RA during pregnancy

An international US-Danish team of scientists, led by Damini Jawaheer, Ph.D. at the UCSF Benioff Children's Hospital [Read More]

Shared decision-making essential to optimal treatment and quality of life for patients with MS

Shared decision-making essential to optimal treatment and quality of life for patients with MS

One of the cornerstones of multiple sclerosis treatment is shared decision-making between patients and their doctors [Read More]

UC consortium formed to speed up development of new drugs

UC consortium formed to speed up development of new drugs

For 12 years, UCLA researcher Dennis Slamon pursued a groundbreaking approach to treating breast cancer: Attack the [Read More]